drugset / Trial / NCT01005823
A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of 7 days treatment with LEO 29102 in adult patients with atopic dermatitis.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | LEO 29102 | Unknown | 0.3 unknown | Topical |
| Comparator | LEO 29102 | Unknown | 1 unknown | Topical |
| Comparator | LEO 29102 | Unknown | 2.5 unknown | Topical |